| SC 13D/A | 2024-04-16 | Soleus Private Equity Fund I, L.P. | BioAtla, Inc. | 1,134,601 | 2.4% | EDGAR |
| SC 13G/A | 2024-02-14 | TANG CAPITAL PARTNERS LP | BioAtla, Inc. | 2,524,076 | 5.3% | EDGAR |
| SC 13G/A | 2024-02-09 | SHORT JAY M PHD | BioAtla, Inc. | 3,458,190 | 7.2% | EDGAR |
| SC 13G/A | 2024-02-06 | ACORN BIOVENTURES, L.P. | BioAtla, Inc. | 1,824,918 | 3.8% | EDGAR |
| SC 13G | 2024-01-29 | BlackRock Inc. | BioAtla, Inc. | 2,884,014 | 6.0% | EDGAR |
| SC 13G | 2023-04-27 | ACORN BIOVENTURES, L.P. | BioAtla, Inc. | 1,314,039 | 2.8% | EDGAR |
| SC 13G/A | 2023-02-27 | SHORT JAY M PHD | BioAtla, Inc. | 2,982,036 | 6.4% | EDGAR |
| SC 13G/A | 2023-02-14 | Cormorant Asset Management, LP | BioAtla, Inc. | 2,499,250 | - | EDGAR |
| SC 13G/A | 2023-02-14 | TANG CAPITAL PARTNERS LP | BioAtla, Inc. | 3,124,076 | 8.6% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | BioAtla, Inc. | 1,931,039 | 4.2% | EDGAR |
| SC 13G/A | 2023-02-06 | WELLINGTON MANAGEMENT GROUP LLP | BioAtla, Inc. | 1,102 | 0.0% | EDGAR |
| SC 13D/A | 2023-01-09 | Soleus Private Equity Fund I, L.P. | BioAtla, Inc. | 1,167,378 | 2.5% | EDGAR |
| SC 13G/A | 2022-06-10 | FMR LLC | BioAtla, Inc. | 315,211 | 0.9% | EDGAR |
| SC 13G | 2022-04-28 | TANG CAPITAL PARTNERS LP | BioAtla, Inc. | 2,288,900 | 6.4% | EDGAR |
| SC 13G/A | 2022-02-14 | Cormorant Asset Management, LP | BioAtla, Inc. | 857,100 | - | EDGAR |
| SC 13G/A | 2022-02-14 | SHORT JAY M PHD | BioAtla, Inc. | 2,701,327 | 7.5% | EDGAR |
| SC 13G/A | 2022-02-11 | PFIZER INC | BioAtla, Inc. | 1,372,052 | 3.9% | EDGAR |
| SC 13G/A | 2022-02-11 | HBM Healthcare Investments (Cayman) Ltd. | BioAtla, Inc. | 1,427,317 | 4.0% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | BioAtla, Inc. | 3,920,672 | 11.1% | EDGAR |
| SC 13G | 2022-02-09 | VANGUARD GROUP INC | BioAtla, Inc. | 2,264,654 | 6.4% | EDGAR |